Aussie medical instruments startup launches in Australia

Aussie startup Medibit has announced it will launch a medical instrument business in Australia this year.

The startup said on Wednesday that it would start shipping a new medical diagnostic instrument, known as a bovie medical unit, to Australian hospitals.

“Medibit’s bovie unit is designed to diagnose and treat diseases including HIV/AIDS, asthma, rheumatoid arthritis, multiple sclerosis, obesity and other serious conditions,” Medibits CEO Matt Pinder said in a statement.

“It has a fully-functional interface and includes a range of useful diagnostic tools for doctors and patients, including a standard, simple to use, online tool for easy access and analysis.”

The startup is targeting the country’s $100 billion hospital supply chain, with Medibity aiming to provide a “completely new and affordable medical tool to patients and health care providers across the country”.

“We are extremely excited to launch Medibite to the Australian market, as we believe Australia’s growing demand for high quality medical diagnostics will have a positive impact on our business,” Mr Pinder added.

“We will be offering Medibites at the and online stores as well as in our retail stores and at our online store in Australia.”

The bovie has a standardised interface and is designed for doctors to use.

Photo: CEO Matt Bovell said the bovie would offer an easy-to-use interface that was able to diagnose HIV, asthma and rheumatism.

“The boey is designed so you can scan, examine, take apart and reassemble your bovie and it is all fully functional,” Mr Boveell said.

“You can get a full diagnostic, including blood tests, skin tests, respiratory tests and more.”

The company’s boeys will be manufactured at a facility in Perth and shipped to the Meditibity site in Sydney, the company said.

The biaverie, which is also known as an MRI, was developed by Dr Günter Düsseldorf, a doctor and inventor who invented the eye-tracking system, and has since become one of the most well-known inventors in the world.

The medical device, which has the potential to replace expensive MRI scanners, has a range that includes a diagnostic suite for all major conditions, including rheumatic heart disease, multiple myeloma, epilepsy, Parkinson’s disease, cancer and more.